MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,832,424,000 | -44.9% | 130,191 | -65.1% | 0.00% | -50.0% |
| Q2 2020 | $12,399,130,000 | +35.3% | 372,682 | +10.7% | 0.01% | +14.3% |
| Q1 2020 | $9,160,850,000 | +2.9% | 336,796 | -25.3% | 0.01% | +40.0% |
| Q4 2019 | $8,899,040,000 | +880.2% | 451,041 | +543.8% | 0.01% | +400.0% |
| Q3 2019 | $907,912,000 | +22.0% | 70,055 | +17.2% | 0.00% | 0.0% |
| Q2 2019 | $744,435,000 | +2.6% | 59,794 | +19.8% | 0.00% | 0.0% |
| Q1 2019 | $725,308,000 | +57.5% | 49,918 | +19.7% | 0.00% | – |
| Q4 2018 | $460,401,000 | -59.3% | 41,703 | -2.9% | 0.00% | -100.0% |
| Q3 2018 | $1,129,874,000 | +32.1% | 42,961 | +2.7% | 0.00% | 0.0% |
| Q2 2018 | $855,137,000 | +47.2% | 41,816 | +30.6% | 0.00% | – |
| Q1 2018 | $581,000,000 | +46.2% | 32,011 | +12.3% | 0.00% | – |
| Q4 2017 | $397,519,000 | -24.6% | 28,496 | 0.0% | 0.00% | – |
| Q3 2017 | $527,177,000 | +11.4% | 28,496 | +1.8% | 0.00% | – |
| Q2 2017 | $473,099,000 | +59.3% | 27,994 | +25.8% | 0.00% | – |
| Q1 2017 | $297,038,000 | +195319.7% | 22,250 | +120.3% | 0.00% | – |
| Q4 2016 | $152,000 | -60.5% | 10,099 | -69.3% | 0.00% | – |
| Q3 2016 | $385,000 | +8.5% | 32,899 | 0.0% | 0.00% | – |
| Q2 2016 | $355,000 | +16.8% | 32,899 | 0.0% | 0.00% | – |
| Q1 2016 | $304,000 | -42.0% | 32,899 | -6.8% | 0.00% | -100.0% |
| Q4 2015 | $524,000 | -0.6% | 35,299 | +10.0% | 0.00% | 0.0% |
| Q3 2015 | $527,000 | -37.0% | 32,099 | -12.5% | 0.00% | 0.0% |
| Q2 2015 | $837,000 | +133.1% | 36,699 | +55.5% | 0.00% | – |
| Q1 2015 | $359,000 | +56.1% | 23,599 | +23.6% | 0.00% | – |
| Q4 2014 | $230,000 | +6.0% | 19,099 | 0.0% | 0.00% | – |
| Q3 2014 | $217,000 | -6.1% | 19,099 | 0.0% | 0.00% | – |
| Q2 2014 | $231,000 | +3.6% | 19,099 | 0.0% | 0.00% | – |
| Q1 2014 | $223,000 | -34.0% | 19,099 | 0.0% | 0.00% | – |
| Q4 2013 | $338,000 | +15.0% | 19,099 | -6.4% | 0.00% | – |
| Q3 2013 | $294,000 | -4.2% | 20,399 | 0.0% | 0.00% | – |
| Q2 2013 | $307,000 | – | 20,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |